Table 1.
Variable | Total (N = 322) | Controls (N = 215) | Cases (N = 107) |
---|---|---|---|
Age, years; mean (SD) | 45 (9) | 44 (9) | 46 (10) |
Male sex | 273 (85%) | 183 (85%) | 90 (84%) |
Race/ethnicity | |||
White non-Hispanic | 160 (50%) | 104 (48%) | 56 (52%) |
Black non-Hispanic | 98 (30%) | 60 (28%) | 38 (36%) |
Hispanic (regardless of race) | 58 (18%) | 46 (21%) | 12 (11%) |
Other | 6 (2%) | 5 (2%) | 1 (1%) |
Pre-ART CD4, cells/mm3; mean (SD) | 242 (174) | 241 (172) | 244 (177) |
Year 1 CD4, cells/mm3; mean (SD) | 420 (213) | 431 (214) | 399 (209) |
Pre-ART HIV-1 RNA, log10 copy/mL; mean (SD) | 4.8 (0.7) | 4.9 (0.8) | 4.7 (0.7) |
Year 1 HIV-1 RNA, <50 copy/mL | 287 (89%) | 192 (89%) | 95 (89%) |
Year 1 CMV IgG, IU/mL | |||
Mean (SD) | 35 (17) | 33 (17) | 38 (15) |
Median (Q1, Q3) | 37 (25, 47) | 35 (22, 45) | 39 (30, 49) |
Year 1 waist circumference, cm; mean (SD)* | 93 (13) | 92 (13) | 93 (13) |
Year 1 waist-hip ratio; mean (SD)** | 0.9 (0.1) | 0.9 (0.1) | 0.9 (0.1) |
History of smoking | 203 (63%) | 122 (57%) | 81 (76%) |
Year 1 # cigarettes/day; mean (SD) | 6 (10) | 5 (9) | 9 (11) |
* Missing data for 25 participants
** Missing data for 26 participants
Results reported as n (%) unless otherwise noted
Abbreviations: ARV, antiretrovirals; CMV, cytomegalovirus; IgG, immunoglobulin G; SD, standard deviation